Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Waxman emphasizes children in tobacco oversight

This article was originally published in The Tan Sheet

Executive Summary

House Energy and Commerce Committee Chairman Henry Waxman says his legislation to give FDA regulatory authority over tobacco would help meet the "biggest challenge" to reducing smoking - preventing children from starting to use tobacco. In a Minnesota Public Radio interview April 8, the California Democrat said he authored the Family Smoking Prevention and Tobacco Control Act, H.R. 1256, which passed the House April 2, in part to "stop cigarette companies from using flavors that would appeal to kids whether they be chocolate flavors or grape flavors or something sweet." Such formulations make the products appear "childlike" and "without any threat to health," he added (1"The Tan Sheet" April 6, 2009, p. 6). The Congressional Budget Office says in an April 13 cost estimate that implementing the bill will cost $10 million between 2010 and 2014, but the requirements will save $20 million between 2010 and 2019. Waxman said he expects the Senate has enough votes to stop a proposed filibuster and will pass the bill after Congress returns from the spring recess April 20 (2"The Tan Sheet" March 23, 2009, p. 12)

You may also be interested in...

Kennedy offers FDA tobacco bill

Senate Health, Education, Labor and Pensions Committee Chairman Edward Kennedy, D-Mass., introduces the Family Smoking Prevention and Tobacco Control Act, S. 982. The bill, offered May 5, is a virtual copy of legislation the House passed to give FDA authority over tobacco products, with only minor technical changes, according to a staffer for the House Energy and Commerce Committee. H.R. 1256, introduced by Energy and Commerce Chairman Rep. Henry Waxman, D-Calif., passed the House in April. Waxman expressed hope that the Senate would pass the legislation after the spring recess, but a staffer for Senate Majority Leader Harry Reid, D-Nev., said the bill is unlikely to reach the Senate floor until after Memorial Day (1"The Tan Sheet" April 20, 2009, In Brief)

Cigarette Tax Hike Sparks NRT Marketing Opportunities

A 62-cent federal cigarette tax hike may push smokers to quit the increasingly expensive habit - creating a marketing opportunity for nicotine replacement therapy makers

Roche Continues To Make The Case For Gantenerumab In Alzheimer’s Disease

The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts